市場調査レポート
商品コード
1504230
体外受精の市場規模、シェア、予測、動向分析:タイプ別、製品別、周期別、用途別、エンドユーザー別-2031年までの世界予測In Vitro Fertilization Market Size, Share, Forecast, & Trends Analysis by Type (Natural, Intracytoplasmic, Minimal), Product (Imaging, Cryosystems, IVF Cabinets, Incubator, Media, Sperm Analyzer), Cycle, Application, End User - Global Forecast to 2031 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
体外受精の市場規模、シェア、予測、動向分析:タイプ別、製品別、周期別、用途別、エンドユーザー別-2031年までの世界予測 |
出版日: 2024年06月01日
発行: Meticulous Research
ページ情報: 英文 275 Pages
納期: 5~7営業日
|
体外受精(IVF)市場は、2024年から2031年にかけてCAGR 7.1%で2031年までに42億米ドルに達すると予測されます。
本レポートでは、広範な2次調査と1次調査、および市場シナリオの詳細な分析を行った上で、主要な業界促進要因、市場抑制要因、機会、課題についての分析を提供しています。体外受精市場の成長は、主に不妊率の増加、体外受精手順の技術的進歩、体外受精による妊娠の高い成功率、社会文化的規範の変化、有利な政府規制と政策、体外受精のコスト削減によってもたらされます。しかし、卵巣過剰刺激症候群や多胎妊娠など、体外受精治療に伴う健康リスクや合併症、不成功周期のリスクがこの市場の成長を抑制しています。
さらに、最良の胚を選択するための着床前遺伝学的検査(PGT)へのアクセスの増加は、体外受精市場で事業を展開するプレーヤーに成長機会を提供すると期待されています。しかし、特に地方では体外受精専門クリニックの数が限られていることや、体外受精によって出生した児の先天性異常のリスクが、体外受精市場における大きな課題となっています。さらに、選択的卵子凍結、選択的単胚移植、体外受精治療におけるAIの統合は、体外受精市場における顕著な動向です。
(*注:SWOT分析は上位5社について提供される)
The In Vitro Fertilization (IVF) market is projected to reach $4.20 billion by 2031 at a CAGR of 7.1% from 2024 to 2031.
After extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges. The growth of the IVF market is primarily driven by increasing infertility rates, technological advancements in IVF procedures, the high success rates of pregnancy through IVF, changing socio-cultural norms, favorable government regulations & policies, and the reducing costs of IVF. However, the health risks & complications associated with IVF treatment, such as ovarian hyperstimulation syndrome and multiple pregnancies, and the risk of unsuccessful cycles restrain the growth of this market.
Furthermore, the increasing access to Preimplantation Genetic Testing (PGT) for selecting the best embryos is expected to offer growth opportunities for the players operating in the IVF market. However, the limited availability of specialized IVF clinics, especially in rural areas, and the risk of birth defects in babies born through IVF are major challenges in the IVF market. Additionally, elective egg freezing, elective single-embryo transfers, and the integration of AI in IVF treatment are prominent trends in the IVF market.
The report offers a competitive landscape based on an extensive assessment of the leading players' product portfolios, geographic presence, and key strategies adopted over the last four years (2020-2024). The key players operating in the in vitro fertilization market are Esco Micro Pte. Ltd. (Singapore), Vitrolife Sweden AB (Sweden), Thermo Fisher Scientific Inc. (U.S.), Rocket Medical plc (U.K.), Kitazato Corporation (Japan), CooperSurgical, Inc. (U.S.), FUJIFILM Irvine Scientific. (U.S.), Hamilton Thorne Inc. (U.S.), Carl Zeiss AG (Germany), FERTIPRO NV (Belgium), and The Baker Company (U.S.).
Among all the products studied in this report, in 2024, the instruments segment is expected to account for the largest share of 62.9% of the in vitro fertilization market. The instruments segment is further categorized into imaging systems, ovum aspiration pumps, micromanipulator systems, gas analyzers, incubators, laser analyzers, cryosystems, sperm separation devices, sperm analyzer systems, sterile cabinets, and other instruments. The rising demand for advanced IVF instruments, high affordability in the private sector, the increasing number of fertility clinics, and rising healthcare expenditures support the segment's large market share.
Among all the applications studied in this report, in 2024, the human reproduction segment is expected to account for the major share of the in vitro fertilization market. The segment's large share is attributed to the increasing demand for IVF due to increasing pregnancy success rates through IVF, rising healthcare expenditures, the increasing demand for IVF due to changing socio-demographic trends, the availability of modern technologies, and decreasing natural fertility rates. For instance, according to the World Health Organization's April 2023 Report, 1 in 6 people globally are affected by infertility.
Based on end user, the IVF market is segmented into hospitals, fertility clinics, research institutes, and cryobanks. In 2024, the fertility clinics segment is expected to account for the largest share of the in vitro fertilization market. The large share of this segment is attributed to the increased adoption of advanced techniques in fertility clinics for the treatment of infertility. Additionally, fertility clinics have specialized expertise and also offer a comprehensive range of services beyond IVF, including counseling and egg freezing. The rising demand for IVF treatments and the increasing number of IVF clinics worldwide are further supporting the segment's large share. For instance, according to the National Center for Chronic Disease Prevention and Health Promotion, Division of Reproductive Health (U.S.), there are approximately 500 fertility clinics in the U.S.
An in-depth analysis of the geographical scenario of the global IVF market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of 42.0% of the in vitro fertilization market. North America's large market share is attributed to the availability of advanced infrastructure, high healthcare expenditures, favorable policies, and the presence of key players with well-established distribution channels in the region. However, Asia-Pacific is expected to register the highest CAGR of 9.4% during the forecast period due to the growing number of individuals with infertility, changing socio-cultural norms, increasing healthcare expenditures, and increasing access to fertility clinics in the region.
In Vitro Fertilization Market Assessment-by Product
Note: Other Instruments include anti-vibration tables, air purification systems, witness systems, glass heaters, and tube warmers.
Note: Other accessories include dishes, pipettes, tubes, sperm-counting chambers, shelves, and microscope slides.
In Vitro Fertilization Market Assessment-by Type
Note: Other types include needle-free IVF, ovarian rejuvenation therapy, and egg freezing.
In Vitro Fertilization Market Assessment-by Cycle
In Vitro Fertilization Market Assessment-by Application
In Vitro Fertilization Market Assessment-by End User
In Vitro Fertilization Market Assessment-by Geography
(*Note: SWOT analysis will be provided for the top 5 companies.)